TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Glottis viewing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subclinical stroke rate
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of emergency cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of lost of the (C)PTSD diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver non-directiveness subscore
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive function measured by MoCA-INA test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Expression of APP, MAPT, BDNF, IL-10, and TGF-β genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of postnatal surfactant doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diagnostic value of the GAAD score for HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Labial bone thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG Amplitude (microvolts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG Latency (milliseconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Standing postural stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with at Least One Serious Adverse Event (SAE) or Adverse Events of Special Interest (AESIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Solicited Local Reactions at the Injection Site
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Solicited Systemic Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with at Least One Unsolicited TEAE
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the Six Minute Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of high-purity magnesium bone plate and screw fixation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Outcome related to brain monitoring parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of participants who score 5-9 on the PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants who score 10-14 on the PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants who score 15-19 on the PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants who score 20-27 on the PHQ-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants who score 5-9 on the GAD-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Referral Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Peristomal Skin Complications (PSCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Dressing Leak Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intrarenal Resistive Index (RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Adverse events during or after endotracheal intubation
Endpoint domain: Adverse events/effects
Primary endpoint: influenza vaccine acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incremental cost-effectiveness ratios (ICERs)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful occlusion rate of aneurysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knee ligament stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional performance and return to sport
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Bayley Scales of Infant Toddler Development-IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ages and Stages Questionnaire-3
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Infant Toddler Activity Card Sort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Behavior Rating Inventory of Executive Function-Preschool
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Diffusion MRI metrics of regional electrical properties in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Small Bowel Obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to Surgical Treatment of Small Bowel Obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in right atrial pressure (RAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in pulmonary artery pulsatility index (PAPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in cardiac power output (CPO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parenting Sense of Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total opioid consumption within the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants with ≥1 Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Discontinuing from Study Therapy Due to AE
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of histological complete remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of AE and SAE
Endpoint domain: Adverse events/effects
Primary endpoint: Anxiety and depression severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Expression levels of MRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive expression of plasma HPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal trauma symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child trauma symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Bladder Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Urine Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Oral Health Impact Profile-14 (OHIP-14)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Jaw Functional Limitation Scale-8 (JFLS-8)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Movement Fear Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Core length of tissue in the sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight of tissue in the sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrences of intraoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrences of Postoperative Morbidity and Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Qualitative feedback on cognitive screens
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes of Keratinized Mucosa width (KMW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fertility Preservation Uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from Baseline Performance Questionnaire at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline InBody Body Composition Test at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Vertical Jump Test at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Botulinum Toxin Type A in treating trigeminal neuralgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: marginal gap distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Euro Quality of Life 5D-3L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical performance (Marginal adaptation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting motor threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Continuous stimulation tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Jumping Ability (CMJ Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Velocity and Power in Back-Squat at 50% and 75% 1RM (Mean and Peak Measurements)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscular Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spleen Volume Reduction (SVR) of >= 35%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Symptom Score (TSS) Reduction of >= 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of preoperative anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in macroscopic aspect of melanocytic nevi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in mole analyzer score with the 2D FotoFinder ATBM master system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Patient rated feasibility and adequacy of the item lists and symptom monitoring program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessment completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gene expression of glutamate-cystein ligase (GCL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total glutathione level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoliosis Research Society (SRS-22 test)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: sway balance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plantar pressure analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine color
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum osmolarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood Urea Nitrogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of urinary infections
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in weight-status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of unexpected adverse events, by severity and relation to study
Endpoint domain: Adverse events/effects
Primary endpoint: Evidence of formation of anti-HLA antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Abstinent from Opioid Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Negative Urine Toxicologies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death from all causes within 30 days of ICU admission
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in the percentage of TIR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Change in Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Sound Quality of Streamed Music Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Own Voice Sound Quality Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of adverse events grade 3 or 4
Endpoint domain: Adverse events/effects
Primary endpoint: Regional-recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Arabic Index of Premature Ejaculation (AIPE)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Presence of spermatazoa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Brief Symptom Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Internship Stress Survey Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Scale Body Connection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Mallet scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Box and block test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein bound uremic toxin reduction ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of withdrawals due to AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Liver transplant volume
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Blood coagulation function indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood flow impedance in uterine arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Angles of inclination of the fuselage to the vertical
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute pain dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of blood pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of serum triglycerides level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assessment of serum total cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pelvic Floor Distress Inventory short-form 20 (PFDI-20)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diagnostic accuracy for ischemic heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time awake after sleep onset (WASO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dipper pattern of blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of postoperative pulmonary infection
Endpoint domain: Adverse events/effects
Primary endpoint: Wound Reduction in Surface Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety/tolerance
Endpoint domain: Adverse events/effects
Primary endpoint: Circadian variability of serum progesterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: improved hand grip degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with independent CIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease of symptomatology related to STT OA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provider-based stigma (SDS measure)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Provider-based stigma (MCRS measure)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Provider-based stigma (planned behavior measure)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presence or absence of NSCLC-specific VOCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with perioperative stroke
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with perioperative death
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of words correctly repeated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrically evoked fatigue resistance (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voluntary isometric quadriceps endurance (time to fatigue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voluntary isokinetic work fatigue index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WHO Ordinal Scale for Clinical Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of significant clinical laboratory test abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of significant vital signs abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants diagnosed with post-operative tenolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of patients accepting long-acting risperidone injection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Naming Response Time of trained items
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Naming Efficiency of trained items
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of study device- and/or Study Ablation Procedure-related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: 12-month freedom from VT recurrence, death, and cardiac transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Change in the score of Patient Health Questionnaire-9
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the score of Generalized Anxiety Disorder Test-7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the score of World Health Organization Quality of Life - BREF (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: effectiveness of insertion of SaCo VLM for airway management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: effectiveness of ventilation using SaCo mask
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: effectiveness of visualisation of larynx using SaCo VLM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: seal pressure of SaCo VLM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hypoglycemic Confidence Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of symptomatic, virologically confirmed COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Patient's preference for impression techniques
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skeletal muscle mitochondrial respiratory capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of skin irritation at application site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Phototoxic potential at application site
Endpoint domain: Adverse events/effects
Primary endpoint: WI-NRS score at week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Center for Epidemiologic Studies Depression Scale-Korean (CESD-K)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Acculturation Stress Scale (ASS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Social Readjustment Rating Scale (SRRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Personal Resource Questionnaire (PRQ-2000)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: DNA damage measured by base pair dimers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the abundance of monocyte-derived alveolar macrophages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of People developing ovarian cancer
Endpoint domain: Mortality/survival
Primary endpoint: Number of People developing endometrial cancer
Endpoint domain: Mortality/survival
Primary endpoint: Stages of Change for Digital Gaming Behavior
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neuropsychological Assessment Battery (NAB) Attention Module
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Susceptibility to Vaping
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Susceptibility to Using Conventional Tobacco
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status